Free Trial

Structure Therapeutics (GPCR) SEC Filings & 10K Form

$34.20
+0.44 (+1.30%)
(As of 05/31/2024 08:50 PM ET)

Recent Structure Therapeutics SEC Filings

DateFilerForm TypeView
05/30/2024
5:57 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
05/09/2024
3:56 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
3:10 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
4:24 PM
Structure Therapeutics (Filer)
Form ARS
04/19/2024
1:13 PM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
6:34 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:37 PM
Structure Therapeutics (Issuer)
Yoon Jun (Reporting)
Form 4/A
03/20/2024
6:39 PM
Ma Yingli (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:41 PM
Bach Mark Allen (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/20/2024
6:42 PM
Lin Xichen (Reporting)
Structure Therapeutics (Issuer)
Form 4/A
03/19/2024
3:36 PM
Stevens Raymond C (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
7:52 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:19 PM
Structure Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/08/2024
8:19 AM
Structure Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2024
7:43 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
10:11 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:07 AM
Avoro Capital Advisors LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G
02/14/2024
7:45 AM
Deep Track Capital, LP (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:49 AM
FMR LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/09/2024
6:59 AM
FIL Ltd (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:01 AM
Structure Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/27/2023
9:49 AM
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
9:49 AM
FMR LLC (Reporting)
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:36 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
12/18/2023
7:28 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
10:04 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
11:15 PM
Structure Therapeutics (Filer)
Form EFFECT
11/17/2023
4:25 PM
Structure Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/17/2023
3:51 PM
Structure Therapeutics (Filer)
Form 10-Q/A
11/17/2023
3:55 PM
Structure Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/16/2023
4:13 PM
Structure Therapeutics (Filer)
Form 10-Q/A
10/23/2023
2:55 PM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
3:00 PM
FMR LLC (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
10/12/2023
7:55 AM
FMR LLC (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/04/2023
11:01 AM
FIL Ltd (Filed by)
Structure Therapeutics (Subject)
Form SC 13G/A
09/29/2023
6:50 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
6:38 AM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
4:37 PM
Structure Therapeutics (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
4:29 PM
LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2023
4:34 PM
LOVE TED W (Reporting)
Structure Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
3:30 PM
Structure Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The only AI company to buy (Ad)

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:GPCR) was last updated on 6/3/2024 by MarketBeat.com Staff

From Our Partners